Company intelligence / Profile preview

Kaneka

Osaka/Nakanoshima Kita-ku, Osaka Prefecture, Japankaneka.co.jp ↗
Ownership
Public · 4118
Employees
~11500
Development stage
Other
01

Overview

Kaneka Corporation is a diversified Japanese chemical company with significant operations in life sciences. Through its subsidiaries like Kaneka Eurogentec S.A. and partnerships/acquisitions such as AB-BIOTICS, it provides CDMO services for plasmid DNA, recombinant proteins, oligonucleotides and mRNA therapeutics/vaccines. It also develops medical devices and nutritional supplements including probiotics. The company has expanded its GMP manufacturing capacity to meet global demand for advanced biologics including mRNA-based drugs.

Therapeutic areas
CardiovascularGastroenterologyOncologyInfectious Diseases
Modalities
Small molecule (e.g., coenzyme Q10)Recombinant proteinOligonucleotidemRNA-based drugsPlasmid DNA therapyProbiotic (Live biotherapeutic product therapy)Medical devices (Device)
Industry
Contract Manufacturing Organization
02

Partnerships

AB-BIOTICS partnership/acquisitioncollaborations with pharmaceutical companies globally through CDMO businesspartnership with ESM for cerebrovascular medical device development

Beyond the preview

Go deeper on Kaneka.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaneka.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call